Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225516166> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4225516166 endingPage "12" @default.
- W4225516166 startingPage "11" @default.
- W4225516166 abstract "Favipiravir has shown promising results for COVID-19 globally. Though many Indian patients have received favipiravir, there is a lack of realworld data for its clinical use by the practicing physicians. Hence, a qualitative survey was conducted to understand real-world use of favipiravir in management of COVID-19.A cross-sectional, web-based, qualitative survey was conducted between September 2020 to October 2020, among Indian physicians from various specialties involved in COVID-19 care and using favipiravir in their practice. Physicians were provided survey link having a structured questionnaire with 32 questions. They were enquired on- 1) demographics,practice information, 2) place of favipiravir in clinical practice, 3) treatment protocol for mild to moderate COVID-19, 4) dosage and duration of favipiravir, 5) effectiveness of favipiravir, 6) tolerability of favipiravir 7) global efficacy and safety assessment of favipiravir.A total of 500 physicians were contacted, of which 50 physicians completed the questionnaire. 25(50.0%) were from south zone followed by 12(24.0%) from west. . Majority physicians (47, 97.9%) stated that favipiravir was used for COVID-19 in outpatient setting. Favipiravir was considered as the current drug of choice for ' mild COVID-19 with fever(86.6%). All physicians agreed that favipiravir was being used as per the recommended dose.. A total of 75% & 62.5% physicians agreed to observed clinical improvement by around 3-5 days & 5-7 days in symptomatic mild & moderate COVID-19 respectively.Majority of the physicians considered favipiravir to be safe and effective in treatment of mild to moderate COVID-19." @default.
- W4225516166 created "2022-05-05" @default.
- W4225516166 creator A5014394376 @default.
- W4225516166 creator A5026538013 @default.
- W4225516166 creator A5027526274 @default.
- W4225516166 creator A5031211495 @default.
- W4225516166 creator A5044886651 @default.
- W4225516166 creator A5046066094 @default.
- W4225516166 creator A5079746705 @default.
- W4225516166 creator A5080910293 @default.
- W4225516166 creator A5090370527 @default.
- W4225516166 date "2022-12-01" @default.
- W4225516166 modified "2023-09-28" @default.
- W4225516166 title "Real-world Experience with Favipiravir for Treatment of COVID-19 among Indian Healthcare Professionals." @default.
- W4225516166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35057588" @default.
- W4225516166 hasPublicationYear "2022" @default.
- W4225516166 type Work @default.
- W4225516166 citedByCount "0" @default.
- W4225516166 crossrefType "journal-article" @default.
- W4225516166 hasAuthorship W4225516166A5014394376 @default.
- W4225516166 hasAuthorship W4225516166A5026538013 @default.
- W4225516166 hasAuthorship W4225516166A5027526274 @default.
- W4225516166 hasAuthorship W4225516166A5031211495 @default.
- W4225516166 hasAuthorship W4225516166A5044886651 @default.
- W4225516166 hasAuthorship W4225516166A5046066094 @default.
- W4225516166 hasAuthorship W4225516166A5079746705 @default.
- W4225516166 hasAuthorship W4225516166A5080910293 @default.
- W4225516166 hasAuthorship W4225516166A5090370527 @default.
- W4225516166 hasConcept C126322002 @default.
- W4225516166 hasConcept C160735492 @default.
- W4225516166 hasConcept C162324750 @default.
- W4225516166 hasConcept C194828623 @default.
- W4225516166 hasConcept C197934379 @default.
- W4225516166 hasConcept C2778375690 @default.
- W4225516166 hasConcept C2779134260 @default.
- W4225516166 hasConcept C2779772310 @default.
- W4225516166 hasConcept C3008058167 @default.
- W4225516166 hasConcept C50522688 @default.
- W4225516166 hasConcept C512399662 @default.
- W4225516166 hasConcept C524204448 @default.
- W4225516166 hasConcept C57658597 @default.
- W4225516166 hasConcept C71924100 @default.
- W4225516166 hasConcept C89623803 @default.
- W4225516166 hasConceptScore W4225516166C126322002 @default.
- W4225516166 hasConceptScore W4225516166C160735492 @default.
- W4225516166 hasConceptScore W4225516166C162324750 @default.
- W4225516166 hasConceptScore W4225516166C194828623 @default.
- W4225516166 hasConceptScore W4225516166C197934379 @default.
- W4225516166 hasConceptScore W4225516166C2778375690 @default.
- W4225516166 hasConceptScore W4225516166C2779134260 @default.
- W4225516166 hasConceptScore W4225516166C2779772310 @default.
- W4225516166 hasConceptScore W4225516166C3008058167 @default.
- W4225516166 hasConceptScore W4225516166C50522688 @default.
- W4225516166 hasConceptScore W4225516166C512399662 @default.
- W4225516166 hasConceptScore W4225516166C524204448 @default.
- W4225516166 hasConceptScore W4225516166C57658597 @default.
- W4225516166 hasConceptScore W4225516166C71924100 @default.
- W4225516166 hasConceptScore W4225516166C89623803 @default.
- W4225516166 hasIssue "12" @default.
- W4225516166 hasLocation W42255161661 @default.
- W4225516166 hasOpenAccess W4225516166 @default.
- W4225516166 hasPrimaryLocation W42255161661 @default.
- W4225516166 hasRelatedWork W12163781 @default.
- W4225516166 hasRelatedWork W16693323 @default.
- W4225516166 hasRelatedWork W18812912 @default.
- W4225516166 hasRelatedWork W21725258 @default.
- W4225516166 hasRelatedWork W3025231 @default.
- W4225516166 hasRelatedWork W3537453 @default.
- W4225516166 hasRelatedWork W7857626 @default.
- W4225516166 hasRelatedWork W8123807 @default.
- W4225516166 hasRelatedWork W20231019 @default.
- W4225516166 hasRelatedWork W3076939 @default.
- W4225516166 hasVolume "69" @default.
- W4225516166 isParatext "false" @default.
- W4225516166 isRetracted "false" @default.
- W4225516166 workType "article" @default.